312 related articles for article (PubMed ID: 22330956)
1. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.
López-Macías C
Hum Vaccin Immunother; 2012 Mar; 8(3):411-4. PubMed ID: 22330956
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.
López-Macías C; Ferat-Osorio E; Tenorio-Calvo A; Isibasi A; Talavera J; Arteaga-Ruiz O; Arriaga-Pizano L; Hickman SP; Allende M; Lenhard K; Pincus S; Connolly K; Raghunandan R; Smith G; Glenn G
Vaccine; 2011 Oct; 29(44):7826-34. PubMed ID: 21816199
[TBL] [Abstract][Full Text] [Related]
3. Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.
Valero-Pacheco N; Pérez-Toledo M; Villasís-Keever MÁ; Núñez-Valencia A; Boscó-Gárate I; Lozano-Dubernard B; Lara-Puente H; Espitia C; Alpuche-Aranda C; Bonifaz LC; Arriaga-Pizano L; Pastelin-Palacios R; Isibasi A; López-Macías C
PLoS One; 2016; 11(2):e0150146. PubMed ID: 26919288
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524
[TBL] [Abstract][Full Text] [Related]
5. Medical Outcomes in Women Who Became Pregnant after Vaccination with a Virus-Like Particle Experimental Vaccine against Influenza A (H1N1) 2009 Virus Tested during 2009 Pandemic Outbreak.
Cérbulo-Vázquez A; Arriaga-Pizano L; Cruz-Cureño G; Boscó-Gárate I; Ferat-Osorio E; Pastelin-Palacios R; Figueroa-Damian R; Castro-Eguiluz D; Mancilla-Ramirez J; Isibasi A; López-Macías C
Viruses; 2019 Sep; 11(9):. PubMed ID: 31533277
[TBL] [Abstract][Full Text] [Related]
6. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
Lee GJ; Chu KB; Inn KS; Moon EK; Quan FS
Immunol Invest; 2020 Oct; 49(7):781-793. PubMed ID: 31774021
[TBL] [Abstract][Full Text] [Related]
7. The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae.
Nerome K; Sugita S; Kuroda K; Hirose T; Matsuda S; Majima K; Kawasaki K; Shibata T; Poetri ON; Soejoedono RD; Mayasari NL; Agungpriyono S; Nerome R
Vaccine; 2015 Jan; 33(1):117-25. PubMed ID: 25448101
[TBL] [Abstract][Full Text] [Related]
8. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
[TBL] [Abstract][Full Text] [Related]
9. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
Hendin HE; Pillet S; Lara AN; Wu CY; Charland N; Landry N; Ward BJ
Vaccine; 2017 May; 35(19):2592-2599. PubMed ID: 28389100
[TBL] [Abstract][Full Text] [Related]
10. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
11. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
Matassov D; Cupo A; Galarza JM
Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
[TBL] [Abstract][Full Text] [Related]
12. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.
Shoji Y; Chichester JA; Jones M; Manceva SD; Damon E; Mett V; Musiychuk K; Bi H; Farrance C; Shamloul M; Kushnir N; Sharma S; Yusibov V
Hum Vaccin; 2011; 7 Suppl():41-50. PubMed ID: 21266846
[TBL] [Abstract][Full Text] [Related]
13. Progress in developing virus-like particle influenza vaccines.
Quan FS; Lee YT; Kim KH; Kim MC; Kang SM
Expert Rev Vaccines; 2016 Oct; 15(10):1281-93. PubMed ID: 27058302
[TBL] [Abstract][Full Text] [Related]
14. Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
Venereo-Sanchez A; Simoneau M; Lanthier S; Chahal P; Bourget L; Ansorge S; Gilbert R; Henry O; Kamen A
Vaccine; 2017 Jul; 35(33):4220-4228. PubMed ID: 28648546
[TBL] [Abstract][Full Text] [Related]
15. Plant-derived virus-like particles as vaccines.
Chen Q; Lai H
Hum Vaccin Immunother; 2013 Jan; 9(1):26-49. PubMed ID: 22995837
[TBL] [Abstract][Full Text] [Related]
16. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
[TBL] [Abstract][Full Text] [Related]
17. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants.
Le Mauff F; Mercier G; Chan P; Burel C; Vaudry D; Bardor M; Vézina LP; Couture M; Lerouge P; Landry N
Plant Biotechnol J; 2015 Jun; 13(5):717-25. PubMed ID: 25523794
[TBL] [Abstract][Full Text] [Related]
18. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
19. A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response.
Hodgins B; Yam KK; Winter K; Pillet S; Landry N; Ward BJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021303
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.
Gwon YD; Kim S; Cho Y; Heo Y; Cho H; Park K; Lee HJ; Choi J; Poo H; Kim YB
PLoS One; 2016; 11(5):e0154824. PubMed ID: 27149064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]